Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.5B | 4.9B | 5.0B | 4.4B |
Cost of revenue | 2.5B | 2.7B | 2.6B | 2.3B |
Gross profit | 2.0B | 2.2B | 2.3B | 2.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 822.0M | 917.3M | 979.8M | 830.9M |
Operating income | 357.8M | 420.2M | 511.2M | 466.8M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 19.0M | 25.1M | 42.8M | 41.9M |
Other income expense | — | — | — | — |
Pretax income | 452.5M | 464.9M | 525.0M | 475.3M |
Tax provision | 109.7M | 119.0M | 135.7M | 121.1M |
Net income | 342.8M | 345.9M | 389.4M | 354.3M |
Basic EPS | — | 5.6 | 6.6 | 6.0 |
Diluted EPS | — | 5.6 | 6.6 | 6.0 |
Basic average shares | — | 61.3M | 59.4M | 58.7M |
Diluted average shares | — | 61.3M | 59.4M | 58.7M |
EBITDA | 669.2M | 684.1M | 761.3M | 690.6M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |